Home / Companies / Cancer Genetics, Inc.

Cancer Genetics, Inc.

FDA Regulatory Profile

Cancer Genetics, Inc. has 0 FDA recalls, 2 inspections, 1 510(k) clearance and 0 compliance actions on record.

Latest inspection
Apr 14, 2016 · NAI
Latest 510(k)
Mar 15, 2018

Reviewing Cancer Genetics, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Request a free FDA snapshot

Or get Cancer Genetics, Inc.'s full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Oct 23, 2026Not statedCurrent
510(k) clearances1Oct 4, 2026Not statedCurrent
Inspections2Oct 26, 2026Not statedCurrent
Compliance actions0Oct 23, 2026Not statedCurrent

Recent FDA Inspections

DateSiteProductClassificationFEI
Apr 14, 2016Los Angeles, CADevicesNo Action Indicated (NAI)3009871276
Nov 30, 2012Los Angeles, CADevicesVoluntary Action Indicated (VAI)3009871276

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

Recent 510(k) Clearances

K-NumberDeviceDate
K173839Tissue of Origin Test Kit-FFPEMar 15, 2018

FDA data resources